Life Science Company News

Results 201 - 220 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Canadian Pharmacists Association responds to new pharmacare legislation, call for inclusion of pharmacists in new pharmacare expert committee

Read more ››
By: PR Newswire Association LLC. - 29 Feb 2024

Aurora Completes Final Repayment of Convertible Senior Notes Representing ~$465 Million in Total Repayments Since 2021; Cannabis Operations Are Now Debt Free[1]

Read more ››
By: PR Newswire Association LLC. - 29 Feb 2024

BrightSpring Health Services, Inc. Reports Financial Results for Fourth Quarter and Full Year 2023 and Provides Full Year 2024 Guidance

Read more ››
By: GlobeNewswire - 29 Feb 2024

Dentsply Sirona Announces Retirement of Eric K. Brandt from the Board of Directors

Read more ››
By: GlobeNewswire - 29 Feb 2024

ANI Pharmaceuticals Reports Fourth Quarter and Record Full-Year 2023 Financial Results and Provides 2024 Guidance

Read more ››
By: GlobeNewswire - 29 Feb 2024

Akero Therapeutics Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Read more ››
By: GlobeNewswire - 29 Feb 2024

Applied UV’s Subsidiary has Purchased the Continuing Business and a Multi-Year Exclusive Global Licensing Agreement With Element Designs

Read more ››
By: GlobeNewswire - 29 Feb 2024

Chimerix Reports Fourth Quarter and Year End 2023 Financial Results and Provides Operational Update

Read more ››
By: GlobeNewswire - 29 Feb 2024

EyePoint Pharmaceuticals to Report Fourth Quarter and Full-Year 2023 Financial Results on March 7, 2024

Read more ››
By: GlobeNewswire - 29 Feb 2024

Amarin Reports Fourth Quarter and Full Year 2023 Financial Results and Provides Business Update

Read more ››
By: GlobeNewswire - 29 Feb 2024

Vantage Hemp Co. Achieves GMP Certification from Australia's Therapeutic Goods Administration

Read more ››
By: GlobeNewswire - 29 Feb 2024

Coave Therapeutics Receives Grant from the ALS Association to Advance its CTx-TFEB Program as a Potential Treatment for All Forms of ALS

Read more ››
By: GlobeNewswire - 29 Feb 2024

EDAP Announces Record Preliminary Fourth Quarter and Full-Year 2023 Revenues

Read more ››
By: GlobeNewswire - 29 Feb 2024

Compass Pathways Announces Fourth Quarter 2023 Financial Results and Business Highlights 

Read more ››
By: GlobeNewswire - 29 Feb 2024

TELA Bio to Announce Fourth Quarter and Full Year 2023 Financial Results

Read more ››
By: GlobeNewswire - 29 Feb 2024

ASLAN Pharmaceuticals Receives Favorable Opinion From the European Patent Office on Composition of Matter Patent Application for Farudodstat

Read more ››
By: GlobeNewswire - 29 Feb 2024

Emergent BioSolutions to Release Fourth Quarter & Full Year 2023 Financial Results, and Conduct Conference Call on March 6, 2024

Read more ››
By: GlobeNewswire - 29 Feb 2024

Milestone Pharmaceuticals Announces Pricing of $30.0 Million Public Offering of Common Shares and Pre-Funded Warrants

Read more ››
By: GlobeNewswire - 29 Feb 2024

Fennec Pharmaceuticals Reports Preliminary Unaudited Net Revenue for Fourth Quarter and Full-Year 2023 Results

Read more ››
By: GlobeNewswire - 29 Feb 2024

Clearside Biomedical to Report Fourth Quarter and Full Year 2023 Financial Results and Provide Corporate Update on Tuesday, March 12, 2024

Read more ››
By: GlobeNewswire - 29 Feb 2024
Results 201 - 220 out of 500 displayed.
«  1  2  3  4  5  6  7  8  9  10 11  12  13  14  15  16  17  18  19  20  21  22  23  24  25 »

Enhance your business development with Biotechgate